Taiko Pharmaceutical Co.,Ltd. 4574.T Stock
Taiko Pharmaceutical Co.,Ltd. Price Chart
Taiko Pharmaceutical Co.,Ltd. 4574.T Financial and Trading Overview
Taiko Pharmaceutical Co.,Ltd. stock price | 359 JPY |
Previous Close | 377 JPY |
Open | 376 JPY |
Bid | 379 JPY x 0 |
Ask | 381 JPY x 0 |
Day's Range | 376 - 382 JPY |
52 Week Range | 356 - 669 JPY |
Volume | 279.7K JPY |
Avg. Volume | 212K JPY |
Market Cap | 17.59B JPY |
Beta (5Y Monthly) | 0.129118 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -76.27 JPY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | December 29, 2021 |
1y Target Est | N/A |
4574.T Valuation Measures
Enterprise Value | 18.08B JPY |
Trailing P/E | N/A |
Forward P/E | 82.608696 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.148381 |
Price/Book (mrq) | 2.1126251 |
Enterprise Value/Revenue | 3.237 |
Enterprise Value/EBITDA | -20.641 |
Trading Information
Taiko Pharmaceutical Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 0.129118 |
52-Week Change | -32.67% |
S&P500 52-Week Change | 20.43% |
52 Week High | 669 JPY |
52 Week Low | 356 JPY |
50-Day Moving Average | 382.64 JPY |
200-Day Moving Average | 452.76 JPY |
4574.T Share Statistics
Avg. Volume (3 month) | 212K JPY |
Avg. Daily Volume (10-Days) | 333.59K JPY |
Shares Outstanding | 46.28M |
Float | 28.8M |
Short Ratio | N/A |
% Held by Insiders | 43.21% |
% Held by Institutions | 14.66% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -60.68% |
Operating Margin (ttm) | -27.96% |
Gross Margin | 39.25% |
EBITDA Margin | -15.68% |
Management Effectiveness
Return on Assets (ttm) | -5.72% |
Return on Equity (ttm) | -35.74% |
Income Statement
Revenue (ttm) | 5.59B JPY |
Revenue Per Share (ttm) | 128.09 JPY |
Quarterly Revenue Growth (yoy) | 87.90% |
Gross Profit (ttm) | 1.08B JPY |
EBITDA | -876000000 JPY |
Net Income Avi to Common (ttm) | -3390000128 JPY |
Diluted EPS (ttm) | -248.7 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 3.12B JPY |
Total Cash Per Share (mrq) | 67.36 JPY |
Total Debt (mrq) | 3.43B JPY |
Total Debt/Equity (mrq) | 43.65 JPY |
Current Ratio (mrq) | 2.707 |
Book Value Per Share (mrq) | 179.871 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Taiko Pharmaceutical Co.,Ltd.
Country | Japan |
State | N/A |
City | Osaka |
Address | 1-4-1, Nishi-Honmachi |
ZIP | 550-0005 |
Phone | 81 6 4391 1110 |
Website | https://www.seirogan.co.jp |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 210 |
Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`
Q&A For Taiko Pharmaceutical Co.,Ltd. Stock
What is a current 4574.T stock price?
Taiko Pharmaceutical Co.,Ltd. 4574.T stock price today per share is 359 JPY.
How to purchase Taiko Pharmaceutical Co.,Ltd. stock?
You can buy 4574.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Taiko Pharmaceutical Co.,Ltd.?
The stock symbol or ticker of Taiko Pharmaceutical Co.,Ltd. is 4574.T.
Which industry does the Taiko Pharmaceutical Co.,Ltd. company belong to?
The Taiko Pharmaceutical Co.,Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Taiko Pharmaceutical Co.,Ltd. have in circulation?
The max supply of Taiko Pharmaceutical Co.,Ltd. shares is 50.15M.
What is Taiko Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Taiko Pharmaceutical Co.,Ltd. PE Ratio is now.
What was Taiko Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Taiko Pharmaceutical Co.,Ltd. EPS is -76.27 JPY over the trailing 12 months.
Which sector does the Taiko Pharmaceutical Co.,Ltd. company belong to?
The Taiko Pharmaceutical Co.,Ltd. sector is Healthcare.
Taiko Pharmaceutical Co.,Ltd. 4574.T included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}